Patents by Inventor Ezra Yagil

Ezra Yagil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of integrase for targeted gene expression
    Patent number: 9816077
    Abstract: There are provided methods and compositions for activating the expression of an exogenous gene by an exogenous integrase specifically in cells in which the exogenous integrase is expressed. The invention further relates to uses of the compositions in treatment of various conditions and disorders, as exemplified by selectively activating expression of a toxin only in target cell populations.
    Type: Grant
    Filed: August 1, 2012
    Date of Patent: November 14, 2017
    Assignee: RAMOT AT TEL-AVIV UNIVERSITY LTD.
    Inventors: Mikhail Kolot, Ezra Yagil, Natalia Malchin
  • USE OF INTEGRASE FOR TARGETED GENE EXPRESSION
    Publication number: 20140171494
    Abstract: There are provided methods and compositions for activating the expression of an exogenous gene by an exogenous integrase specifically in cells in which the exogenous integrase is expressed. The invention further relates to uses of the compositions in treatment of various conditions and disorders, as exemplified by selectively activating expression of a toxin only in target cell populations.
    Type: Application
    Filed: August 1, 2012
    Publication date: June 19, 2014
    Applicant: RAMOT AT TEL-AVIV UNIVERSITY LTD.
    Inventors: Mikhail Kolot, Ezra Yagil, Natalia Malchin